LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise. LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise.

X

Digital content for Soligenix

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Soligenix
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
29 Emmons Drive Suite B-10 Princeton, NJ 08540
Telephone
Telephone
609-538-8200

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/soligenix-announces-european-patent-grant-for-use-of-dusquetide-in-oral-mucositis-301825610.html

PR NEWSWIRE
16 May 2023

https://www.prnewswire.com/news-releases/soligenix-announces-recent-accomplishments-and-first-quarter-2023-financial-results-301823474.html

PR NEWSWIRE
15 May 2023

https://www.prnewswire.com/news-releases/soligenix-announces-scheduling-of-type-a-meeting-with-the-us-fda-to-review-proposed-study-design-for-a-second-phase-3-study-evaluating-hybryte-in-the-treatment-of-cutaneous-t-cell-lymphoma-301821894.html

PR NEWSWIRE
11 May 2023

https://www.prnewswire.com/news-releases/soligenix-announces-closing-of-8-5-million-public-offering-301820032.html

PR NEWSWIRE
09 May 2023

https://www.prnewswire.com/news-releases/soligenix-announces-appointment-of-timothy-r-cote-md-to-its-board-of-directors-301814302.html

BUSINESSWIRE
03 May 2023

https://www.prnewswire.com/news-releases/soligenix-enters-into-exclusive-option-agreement-with-silk-road-therapeutics-for-rights-to-topical-pentoxifylline-designed-to-treat-behcets-disease-301811424.html

PR NEWSWIRE
01 May 2023

https://www.prnewswire.com/news-releases/soligenix-submits-type-a-meeting-request-to-us-fda-to-review-proposed-study-design-for-a-second-phase-3-study-evaluating-hybryte-in-the-treatment-of-cutaneous-t-cell-lymphoma-301804889.html

PR NEWSWIRE
24 Apr 2023

https://www.fiercebiotech.com/biotech/soligenixs-stock-takes-another-hit-fda-requests-2nd-trial-rare-cancer-candidate

FIERCE BIOTECH
15 Apr 2023

https://www.prnewswire.com/news-releases/soligenix-receives-usan-approval-for-hypericin-sodium-as-nonproprietary-name-for-novel-active-ingredient-in-hybryte-and-sgx302-301790440.html

PR NEWSWIRE
05 Apr 2023

https://www.prnewswire.com/news-releases/soligenix-announces-scheduling-of-type-a-meeting-with-the-us-fda-for-hybryte-new-drug-application-in-the-treatment-of-cutaneous-t-cell-lymphoma-301786786.html

PR NEWSWIRE
03 Apr 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY